FindTrial
Sign In

Relation of Oxygen saturation, respiratory rate ratios with failure of high flow oxygen therapy in Corona patients

Relationship of ROX and Modified ROX index with High Flow Nasal Cannula oxygen therapy in COVID 19 patients: An observational pilot study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/01/030431
Enrollment
30
Registered
2021-01-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

All India Institute of Medical Sciences Raipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. On HFNO therapy 2. admitted to ICU / HDU with continuous SpO2 and RR monitoring

Exclusion criteria

Exclusion criteria: 1. Pre-existing respiratory disease: COPD, Bronchial Asthma, idiopathic pulmonary fibrosis

Design outcomes

Primary

MeasureTime frame
Failure of HFNO (if any)Timepoint: baseline, 12h, 24h, 36h, 48h, 60h, 72h, 84h, 96h, 108h, 120h, or at failure point—

Secondary

MeasureTime frame
NoneTimepoint: 0—

Countries

India

Contacts

Public ContactHabib Md Reazaul Karim

All India Institute of Medical Sciences, Raipur

drhabibkarim@gmail.com9612372585

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026